Association between different insulin resistance surrogates and all-cause mortality in patients with coronary heart disease and hypertension: NHANES longitudinal cohort study
This study aimed to explore ... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - February 28, 2024 Category: Cardiology Authors: Xin-Zheng Hou, Yan-Fei Lv, Yu-Shan Li, Qian Wu, Qian-Yu Lv, Ying-Tian Yang, Lan-Lan Li, Xue-Jiao Ye, Chen-Yan Yang, Man-Shi Wang, Lin-Lin Cao and Shi-Han Wang Tags: Research Source Type: research
Non-insulin-based insulin resistance indexes in predicting atrial fibrillation recurrence following ablation: a retrospective study
Insulin resistance (IR) is involved in the pathophysiological processes of arrhythmias. Increasing evidence suggests triglyceride and glucose (TyG) index, metabolic score for insulin resistance (METS-IR), trig... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - February 28, 2024 Category: Cardiology Authors: Zhe Wang, Haoming He, Yingying Xie, Jiaju Li, Fangyuan Luo, Zhaowei Sun, Shuwen Zheng, Furong Yang, Xuexi Li, Xiaojie Chen, Yingwei Chen and Yihong Sun Tags: Research Source Type: research
Effect of SGLT-2 inhibitors on arrhythmia events: insight from an updated secondary analysis of > 80,000 patients (the SGLT2i—Arrhythmias and Sudden Cardiac Death)
We aimed to assess the effect of SGLT2i on arrhythmias by conducting a meta-analysis using data from randomized controlled trials(RCTs). (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - February 24, 2024 Category: Cardiology Authors: Jia Liao, Ramin Ebrahimi, Zhiyu Ling, Christian Meyer, Martin Martinek, Philipp Sommer, Piotr Futyma, Davide Di Vece, Alexandra Schratter, Willem-Jan Acou, Lin Zhu, M árcio G. Kiuchi, Shaowen Liu, Yuehui Yin, Helmut Pürerfellner, Christian Templin & hel Tags: Research Source Type: research
Insulin resistance and coronary inflammation in patients with coronary artery disease: a cross-sectional study
Insulin resistance (IR) is associated with coronary artery disease (CAD) severity. However, its underlying mechanisms are not fully understood. Therefore, our study aimed to explore the relationship between IR... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - February 24, 2024 Category: Cardiology Authors: Tingjie Yang, Guoyong Li, Che Wang, Guian Xu, Qingman Li, Yapan Yang, Lijie Zhu, Lulin Chen, Xueqing Li and Honghui Yang Tags: Research Source Type: research
Link between triglyceride-glucose-body mass index and future stroke risk in middle-aged and elderly chinese: a nationwide prospective cohort study
Current literature is deficient in robust evidence delineating the correlation between the triglyceride glucose-body mass index (TyG-BMI) and the incidence of stroke. Consequently, this investigation seeks to ... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - February 24, 2024 Category: Cardiology Authors: Yuankai Shao, Haofei Hu, Qiming Li, Changchun Cao, Dehong Liu and Yong Han Tags: Research Source Type: research
Intensive lifestyle intervention in type 2 diabetes and risk of incident coronary artery disease for the common haptoglobin phenotypes: the Look AHEAD study
Intensive glycemic control reduced coronary artery disease (CAD) events among the Action to Control Cardiovascular Disease Risk in Diabetes (ACCORD) participants with the haptoglobin (Hp) 2-2 phenotype only. I... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - February 24, 2024 Category: Cardiology Authors: Rachel A. Warren, Michael P. Bancks, Allie S. Carew, Andrew P. Levy, John Sapp, Judy Bahnson, Cora E. Lewis, Eric B. Rimm, Mark A. Espeland and Leah E. Cahill Tags: Research Source Type: research
Distribution and prognostic value of high-sensitivity cardiac troponin T and I across glycemic status: a population-based study
Whether distributions and prognostic values of high-sensitivity cardiac troponin (hs-cTn) T and I are different across normoglycemic, prediabetic, and diabetic populations is unknown. (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - February 24, 2024 Category: Cardiology Authors: Jiajun Zhang, Xiaoxing Li, Shenglin Zhang, Zhen Wang, Rui Tian, Feng Xu, Yuguo Chen and Chuanbao Li Tags: Research Source Type: research
Correction: Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes
(Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - February 20, 2024 Category: Cardiology Authors: Monica Gamez, Hesham E. Elhegni, Sarah Fawaz, Kwan Ho Ho, Neill W. Campbell, David A. Copland, Karen L. Onions, Matthew J. Butler, Elizabeth J. Wasson, Michael Crompton, Raina D. Ramnath, Yan Qiu, Yu Yamaguchi, Kenton P. Arkill, David O. Bates, Jeremy E. Tags: Correction Source Type: research
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus
Early since the onset of the COVID-19 pandemic, the medical and scientific community were aware of extra respiratory actions of SARS-CoV-2 infection. Endothelitis, hypercoagulation, and hypofibrinolysis were i... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - February 20, 2024 Category: Cardiology Authors: In és Valencia, Jairo Lumpuy-Castillo, Giselle Magalhaes, Carlos F. Sánchez-Ferrer, Óscar Lorenzo and Concepción Peiró Tags: Review Source Type: research
Associations of the triglyceride-glucose index and atherogenic index of plasma with the severity of new-onset coronary artery disease in different glucose metabolic states
The triglyceride-glucose (TyG) index is considered a dependable biomarker for gauging insulin resistance. The atherogenic index of plasma (AIP) represents a marker reflecting atherosclerosis. However, there is... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - February 20, 2024 Category: Cardiology Authors: Xiaosheng Wu, Weiping Qiu, Huancheng Yang, Yan-Jun Chen, Jianling Liu and Guojun Zhao Tags: Research Source Type: research
The association between the AIP and undiagnosed diabetes in ACS patients with different body mass indexes and LDL-C levels: findings from the CCC-ACS project
This study aimed to investigate the association between the AIP and u... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - February 20, 2024 Category: Cardiology Authors: Shuwan Xu, Jun Liu, Dong Zhao, Na Yang, Yongchen Hao, Yan Zhou, Dan Zhu and Ming Cui Tags: Research Source Type: research
Prognostic effect of stress hyperglycemia ratio on patients with severe aortic stenosis receiving transcatheter aortic valve replacement: a prospective cohort study
Stress hyperglycemia ratio (SHR) has recently been recognized as a novel biomarker that accurately reflects acute hyperglycemia status and is associated with poor prognosis of heart failure. We evaluated the r... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - February 16, 2024 Category: Cardiology Authors: Xiangming Hu, Dejing Feng, Yuxuan Zhang, Can Wang, Yang Chen, Guannan Niu, Zheng Zhou, Zhenyan Zhao, Hongliang Zhang, Moyang Wang and Yongjian Wu Tags: Research Source Type: research
Association of plasma angiogenin with risk of major cardiovascular events in type 2 diabetes
Angiogenin, an enzyme belonging to the ribonucleases A superfamily, plays an important role in vascular biology. Here, we sought to study the association of plasma angiogenin and major adverse cardiovascular e... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - February 15, 2024 Category: Cardiology Authors: Resham L. Gurung, Sylvia Liu, Jian-Jun Liu, Yiamunaa M., Huili Zheng, Clara Chan, Keven Ang, Tavintharan Subramaniam, Chee Fang Sum and Su Chi Lim Tags: Research Source Type: research
Efficacy and safety of enavogliflozin vs. dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus based on renal function: a pooled analysis of two randomized controlled trials
We assessed the efficacy and safety of enavogliflozin (0.3 mg), a newly developed SGLT-2 inhibitor, in patients with type 2 diabetes mellitus based on kidney function via pooled analysis of two 24-week, random... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - February 15, 2024 Category: Cardiology Authors: Young Sang Lyu, Sangmo Hong, Si Eun Lee, Bo Young Cho and Cheol-Young Park Tags: Research Source Type: research
The effectiveness of sodium-glucose co-transporter 2 inhibitors on cardiorenal outcomes: an updated systematic review and meta-analysis
The 2022 Canadian Cardiovascular Society (CCS) cardiorenal guideline provided clinical recommendations on sodium-glucose co-transport 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1R... (Source: Cardiovascular Diabetology)
Source: Cardiovascular Diabetology - February 15, 2024 Category: Cardiology Authors: Muhammad Usman Ali, G. B. John Mancini, Donna Fitzpatrick-Lewis, Kim A. Connelly, Eileen O ’Meara, Shelley Zieroth and Diana Sherifali Tags: Review Source Type: research
